Johannes Franciscus Diependaal
Direttore/Membro del Consiglio presso Insmed Innovation UK Ltd.
Posizioni attive di Johannes Franciscus Diependaal
Società | Posizione | Inizio | Fine |
---|---|---|---|
Insmed Innovation UK Ltd.
Insmed Innovation UK Ltd. Miscellaneous Commercial ServicesCommercial Services Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom. | Direttore/Membro del Consiglio | 30/06/2023 | - |
Storia della carriera di Johannes Franciscus Diependaal
Statistiche
Distribuzione geografica
Regno Unito | 2 |
Posizioni
Director/Board Member | 1 |
Settori
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
Insmed Innovation UK Ltd.
Insmed Innovation UK Ltd. Miscellaneous Commercial ServicesCommercial Services Adrestia Therapeutics Ltd. engages in the development of therapeutics by restoring the biological balance in damaged, diseased or dying cells. The company was founded by Stephen Philip Jackson, Gabriel Balmus, Yaron Galanty and Rafael Carazo Salas and is headquartered in Cambridge, the United Kingdom. | Commercial Services |